Grant: Alliance Grants
University of Waterloo
$25,000.00
Understand Corneal Stem Cell Niche with 3D Microfabrication Platform
FY 2023-24
Summary
Regenerative medicine has been a promising strategy in developing functional tissue and cells for transplantation and disease studies. The global regenerative medicine market size was valued at USD 27.29 billion in 2020. Canada has also been actively developing the cell and vaccine biomanufacturing industry. An important area is the cell therapy treatment for corneal blindness. Due to the global shortage of donor corneas for transplantation, alternative therapies such as cell therapy is in crucial need. However, human corneal endothelial cells (CECs) lack capacity to grow in vitro, and the lack of knowledge in the mechanism and composition of the corneal stem cell niche limits the use of corneal stem cell as potential cell therapy. This gap in research is the focus of this Catalyst grant application. The understanding of the mechanism to recapitulate the signal from the microenvironment in the will be crucial to derive and generate CECs. To decouple the different factors in the complex microenvironment of the stem cell niche, single cell analysis allows the study of cell-response to biochemicals and cell-extracellular matrix (ECM) interactions, allowing the identification of the essential factors supporting stem cell growth. Dr. Yim at the University of Waterloo (UW) is an expert on corneal endothelial regeneration research, and Dr. Chan at the University of Hong Kong (HKU) is a pioneer in the application of multiphoton microfabrication in micropatterning (MMM) to study biochemical properties of microenvironment. The objective of this Catalyst grant is to develop and utilize single cell analysis MMM platform to identify the crucial factors to develop biomaterials and bioreactor to derive and manufacture corneal CECs. Yim lab at UW and Chan lab at HKU will jointly develop the MMM platform with varying ECM and biochemical composition to mimic the microenvironment in the corneal stem cell niche. The expected outcomes including the understanding and design of in vitro stem cell niche will enable the biomanufacturing of the CECs for cell therapy. The impact will enable Canadian biomanufacturing industry to produce CECs in a cost effective manner.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
580552-2022
Name nom
Yim, Evelyn KFE
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical technology
Research subject en
Génie biomédical
Research subject fr
Technologie biomédicale
Application title
Understand Corneal Stem Cell Niche with 3D Microfabrication Platform
Keyword
Basement membrane; Biomaterials; Biomechanics; Corneal endothelial cells; Corneal endothelial stem cells; Descemet's membrane; Extracellular matrix; Extracellular microenvironment; Multi-photo microfabrication; Stem cells
Application summary
Regenerative medicine has been a promising strategy in developing functional tissue and cells for transplantation and disease studies. The global regenerative medicine market size was valued at USD 27.29 billion in 2020. Canada has also been actively developing the cell and vaccine biomanufacturing industry. An important area is the cell therapy treatment for corneal blindness. Due to the global shortage of donor corneas for transplantation, alternative therapies such as cell therapy is in crucial need. However, human corneal endothelial cells (CECs) lack capacity to grow in vitro, and the lack of knowledge in the mechanism and composition of the corneal stem cell niche limits the use of corneal stem cell as potential cell therapy. This gap in research is the focus of this Catalyst grant application. The understanding of the mechanism to recapitulate the signal from the microenvironment in the will be crucial to derive and generate CECs. To decouple the different factors in the complex microenvironment of the stem cell niche, single cell analysis allows the study of cell-response to biochemicals and cell-extracellular matrix (ECM) interactions, allowing the identification of the essential factors supporting stem cell growth. Dr. Yim at the University of Waterloo (UW) is an expert on corneal endothelial regeneration research, and Dr. Chan at the University of Hong Kong (HKU) is a pioneer in the application of multiphoton microfabrication in micropatterning (MMM) to study biochemical properties of microenvironment. The objective of this Catalyst grant is to develop and utilize single cell analysis MMM platform to identify the crucial factors to develop biomaterials and bioreactor to derive and manufacture corneal CECs. Yim lab at UW and Chan lab at HKU will jointly develop the MMM platform with varying ECM and biochemical composition to mimic the microenvironment in the corneal stem cell niche. The expected outcomes including the understanding and design of in vitro stem cell niche will enable the biomanufacturing of the CECs for cell therapy. The impact will enable Canadian biomanufacturing industry to produce CECs in a cost effective manner.